CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with ...
Seattle, Washington, United States and 1 other location
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Seattle, Washington, United States and 17 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Tacoma, Washington, United States and 9 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Seattle, Washington, United States and 24 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Bellevue, Washington, United States of America and 42 other locations
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
Seattle, Washington, United States and 47 other locations
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Seattle, Washington, United States and 35 other locations
BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setti...
Phase 4
Seattle, Washington, United States
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Seattle, Washington, United States and 19 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Seattle, Washington, United States and 654 other locations
Clinical trials
Research sites
Resources
Legal